0000925421-23-000018.txt : 20230829 0000925421-23-000018.hdr.sgml : 20230829 20230829165656 ACCESSION NUMBER: 0000925421-23-000018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230829 DATE AS OF CHANGE: 20230829 EFFECTIVENESS DATE: 20230829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Skye Bioscience, Inc. CENTRAL INDEX KEY: 0001516551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450692882 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490948 FILM NUMBER: 231222716 BUSINESS ADDRESS: STREET 1: 11250 EL CAMINO REAL, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 410-0266 MAIL ADDRESS: STREET 1: 11250 EL CAMINO REAL, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Emerald Bioscience, Inc. DATE OF NAME CHANGE: 20190325 FORMER COMPANY: FORMER CONFORMED NAME: Nemus Bioscience, Inc. DATE OF NAME CHANGE: 20141030 FORMER COMPANY: FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC. DATE OF NAME CHANGE: 20121107 D 1 primary_doc.xml X0708 D LIVE 0001516551 Skye Bioscience, Inc. 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA CALIFORNIA 92130 (858) 410-0266 NEVADA Load Guard Transportation, Inc. Emerald Bioscience, Inc. Nemus Bioscience, Inc. LOAD GUARD LOGISTICS, INC. Corporation true Punit Dhillon 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Executive Officer Director Chief Executive Officer, Chairman and Director Kaitlyn Arsenault 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Executive Officer Chief Financial Officer Margaret Dalesandro 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Deborah Charych 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Praveen Tyle 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Keith Ward 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Andrew Schwab 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Paul Grayson 11250 El Camino Real Suite 100 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2023-08-15 false true true true true true A portion of this offering is made pursuant to that certain Agreement and Plan of Merger and Reorganization, dated August 15, 2023, by and among Skye Bioscience, Inc., Aquila Merger Sub, Inc., and Bird Rock Bio, Inc. (the "Merger Agreement"). 0 62254435 62254435 0 For a description of these transactions, see the Company's Current Report on Form 8-K, as filed with the SEC on August 21, 2023. false 12 0 0 0 false Skye Bioscience, Inc. /s/ Kaitlyn Arsenault Kaitlyn Arsenault Chief Financial Officer 2023-08-29